Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (1918)	9/29/1997 11:13:00 PM
From: JOHN W.	of 6136

Thats fine margie. I am very confident very favorable, and vice today's study, reliable data will be presented regarding cross-resistance. If thestreet.com doesn't release this favorable info from ICAAC they are just manipulators of the price for the shorts. Then we need to start writing the SEC, not e-mailing the editor. I am also confidant that they will post the favorable guidelines released about infant treatment with Viracept as one of two PIs approved. Lets give them the benefit of the doubt and assume that it was unbiased news reporting.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next